71 related articles for article (PubMed ID: 7972805)
21. [Superparamagnetic iron oxide in the differential diagnosis of focal hepatic lesions using a 0.5-tesla magnetic resonance apparatus].
Di Cesare E; Cariello G; Marchese F; Michelini O; Costanzi A; Catalucci A; Splendiani A; Masciocchi C
Radiol Med; 1998 Jun; 95(6):593-8. PubMed ID: 9717541
[TBL] [Abstract][Full Text] [Related]
22. Superparamagnetic iron oxide: detection of focal liver lesions at high-field-strength MR imaging.
Duda SH; Laniado M; Kopp AF; Grönewäller E; Aicher KP; Pavone P; Jehle E; Claussen CD
J Magn Reson Imaging; 1994; 4(3):309-14. PubMed ID: 8061426
[TBL] [Abstract][Full Text] [Related]
23. [Detection of liver lesions: magnetic resonance tomography using superparamagnetic iron particles (AMI-25, endorem) as a contrast medium in comparison with ultrasound diagnosis, computerized tomography and CT portography].
Pleger B; Beyer HK; Laufer U
Rontgenpraxis; 2001; 53(6):245-9. PubMed ID: 11402872
[No Abstract] [Full Text] [Related]
24. Contrast-enhanced MRI of focal liver lesions: differentiation and detection of primary and secondary liver lesions using Resovist-enhanced versus gadolinium-enhanced MRI in the same patient.
Hammerstingl R; Vogl TJ; Schwarz W; Kümmel S; Balzer T; Neuhaus P; Felix R
Acad Radiol; 1998 Apr; 5 Suppl 1():S75-9; discussion S93-4. PubMed ID: 9561049
[No Abstract] [Full Text] [Related]
25. Resovist enhanced MR imaging of the liver: does quantitative assessment help in focal lesion classification and characterization?
Santoro L; Grazioli L; Filippone A; Grassedonio E; Belli G; Colagrande S
J Magn Reson Imaging; 2009 Nov; 30(5):1012-20. PubMed ID: 19856433
[TBL] [Abstract][Full Text] [Related]
26. Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging.
Saini S; Edelman RR; Li W; Petersein J; Hahn PF
Acad Radiol; 1996 Aug; 3 Suppl 2():S409-12. PubMed ID: 8796616
[No Abstract] [Full Text] [Related]
27. Results of a multicenter phase II clinical trial with a susceptibility contrast medium for magnetic resonance imaging of the liver.
Balzer T; Carter EC; Shamsi K; Niendorf HP
Acad Radiol; 1996 Aug; 3 Suppl 2():S417-9. PubMed ID: 8796619
[No Abstract] [Full Text] [Related]
28. Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI.
Chou CT; Chen RC; Chen WT; Lii JM
Br J Radiol; 2010 Dec; 83(996):1023-8. PubMed ID: 20413445
[TBL] [Abstract][Full Text] [Related]
29. Liver MR imaging with iron oxides: toward consensus and clinical practice.
Weissleder R
Radiology; 1994 Dec; 193(3):593-5. PubMed ID: 7972790
[No Abstract] [Full Text] [Related]
30. [Focal intrahepatic siderosis, diagnostic pitfall, iatrogenic image].
Arteaga C; Raillat A; Salamand P; Debonne JM; Bonnet D; Martet G; Veuillet MO; Battini-Nouzille A; Briant JF
J Radiol; 1998 Feb; 79(2):157-8. PubMed ID: 9757234
[No Abstract] [Full Text] [Related]
31. Receptor imaging: application to MR imaging of liver cancer.
Reimer P; Weissleder R; Lee AS; Wittenberg J; Brady TJ
Radiology; 1990 Dec; 177(3):729-34. PubMed ID: 2243978
[TBL] [Abstract][Full Text] [Related]
32. Experience with Resovist in gastroenterologic radiology and intervention.
Vogl TJ; Schwarz W; Marquart F; Parmentier S; Götz B; Thalhammer A; Hammerstingl R
Eur Radiol; 2004 Jan; 14 Suppl 1():C7-9. PubMed ID: 15113060
[No Abstract] [Full Text] [Related]
33. Lesion/fat intensity ratio in MR characterization of hepatic masses.
Marti-Bonmati L; Torrijo C; Vilar J; Ronchera C; Paniagua JC; Talens A
J Comput Assist Tomogr; 1991; 15(4):539-41. PubMed ID: 1648111
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance imaging in the diagnosis of tumors of the liver.
Kinami Y; Yokota H; Takata M; Takashima S; Yamamoto I
Gastroenterol Jpn; 1988 Apr; 23(2):139-46. PubMed ID: 2838374
[TBL] [Abstract][Full Text] [Related]
35. Primary liver tumors in children: comparison of CT and MR imaging.
Boechat MI; Kangarloo H; Ortega J; Hall T; Feig S; Stanley P; Gilsanz V
Radiology; 1988 Dec; 169(3):727-32. PubMed ID: 2847233
[TBL] [Abstract][Full Text] [Related]
36. [Solitary hypovascular hepatic nodules: MR characterization and differential diagnosis].
Qian H; Lin G; Ji M; Lu C; Li C
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):445-50. PubMed ID: 26463149
[TBL] [Abstract][Full Text] [Related]
37. Chondroitin sulfate iron colloid as an MR contrast agent for the hepatic reticuloendothelial system.
Kato T; Suto Y; Matsuo T
J Comput Assist Tomogr; 1993; 17(4):603-8. PubMed ID: 8392526
[TBL] [Abstract][Full Text] [Related]
38. Differential characterization of hepatic tumors in MR imaging by burst-released Mn
Kim JG; Jang MS; Kumari N; Choi JK; Im GH; Kwon T; Lee JH; Lee WJ; Lee IS
Biomaterials; 2020 Feb; 230():119600. PubMed ID: 31727420
[TBL] [Abstract][Full Text] [Related]
39. MR imaging of hepatic metastases.
Pedro MS; Semelka RC; Braga L
Magn Reson Imaging Clin N Am; 2002 Feb; 10(1):15-29. PubMed ID: 11998572
[TBL] [Abstract][Full Text] [Related]
40. MR imaging characteristics of hepatic tumors.
Martí-Bonmatí L
Eur Radiol; 1997; 7(2):249-58. PubMed ID: 9038126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
